Development of a prostate cancer PDX model radioresistant to PSMA targeted radionuclide therapy

被引：0
|
作者：
Thaysen, Maria
Christensen, Esben
Nielsen, Rikke N.
Wick, Michael
Wessel, Mette M.
Kristensen, Lotte K.
Gnosa, Sebastian
Nielsen, Carsten H.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5039
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Theranostics. PSMA ligands formolecular imaging and radionuclide therapy of advanced prostate cancer
    Baum, Richard P.
    Kulkarni, Harshad R.
    Albers, Peter
    ONKOLOGE, 2017, 23 (08): : 597 - 608
  • [42] First results with Lu-177-PSMA617 in targeted radionuclide therapy of patients with metastatic hormone-refractory prostate cancer
    Kratochwil, C.
    Giesel, F. L.
    Afshar-Oromieh, A.
    Benesova, M.
    Mier, W.
    Eder, M.
    Kopka, K.
    Haberkorn, U.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S130 - S130
  • [43] Prostate-Specific Membrane Antigen (PSMA) targeted prodrug "smartbombs" as therapy for prostate cancer
    Mhaka, Annastasiah
    Singh, Pratap
    Rosen, Marc
    Dionne, Craig A.
    Christensen, Soeren B.
    Isaacs, John T.
    Denmeade, Samuel R.
    CANCER RESEARCH, 2006, 66 (08)
  • [44] Practical Guide to 177Lutetium PSMA Peptide Receptor Radionuclide Therapy for Prostate Cancer
    Jang, Samuel
    Kendi, Ayse
    Lunn, Brendan
    Johnson, Geoffrey
    Packard, Ann
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [45] Molecularly targeted radionuclide therapy modulates the composition of the murine prostate cancer microenvironment
    Potluri, Hemanth
    Hernandez, Reinier
    Zahm, Christopher
    Grudzinski, Joseph
    Massey, Christopher
    Weichert, Jamey
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [46] A combination isotope approach towards improved PSMA-targeted radioligand therapy in a murine model of prostate cancer
    Meyer, Catherine
    Stuparu, Andreea
    Wei, Liu
    Radu, Caius
    Calais, Jeremie
    Czernin, Johannes
    Dahlbom, Magnus
    Slavik, Roger
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [47] Association of noninvasive, radiographic measurement of prostate-specific membrane antigen (PSMA) expression with response to PSMA-targeted radionuclide therapy (TRT).
    Vlachostergios, Panagiotis J.
    Niaz, Muhammad Junaid
    Mosallaie, Seyed Ali
    Christos, Paul J.
    Hackett, Amy
    Osborne, Joseph R.
    Jhanwar, Yuliya
    Gracey, Lauren
    Molina, Ana M.
    Nanus, David M.
    Bander, Neil Harrison
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] Consistency among different PSMA ligands for defining PSMA-overexpression prior to PSMA-targeted therapy in prostate cancer
    Heilinger, Jan
    Weindler, Jasmin
    Roth, Katrin
    Krapf, Philipp
    Neumaier, Bernd
    Schomaecker, Klaus
    Dietlein, Markus
    Drzezga, Alexander
    Kobe, Carsten
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [49] Evaluation of a PSMA-Targeted PAMAM Dendrimer in an Experimental Model of Prostate Cancer
    Lesniak, Wojciech
    Ray, Sangeeta
    Boinapally, Srikanth
    Azad, Babak Behnam
    Pomper, Martin
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [50] Development of [161Tb]Tb-DOTA-HYNIC-panPSMA for targeted radionuclide therapy of prostate cancer
    Morgat, C.
    Vimont, D.
    Attia, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S255 - S255
12345